---
schema_version: "secwatch.filing_event.v1"
accession: "0001178670-25-000031"
form_type: "8-K"
ticker: "ALNY"
cik: "0001178670"
company_name: "ALNYLAM PHARMACEUTICALS, INC."
filed_at: "2025-03-05T23:59:59+00:00"
generated_at: "2026-05-25T09:32:28.622186+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Alnylam co-founder Dr. Phillip A. Sharp to retire from board effective May 8, 2025

## Summary
- Dr. Sharp informed the board on March 3, 2025; retirement is not due to any disagreement.
- He will continue to serve on Alnylam's Scientific Advisory Board after retirement.
- Dr. Sharp co-founded Alnylam in 2002 and is a Nobel Prize winner for RNA splicing.
- The company issued a press release on March 5, 2025 announcing the transition.

## SEC filing metadata
- accession: 0001178670-25-000031
- form_type: 8-K
- ticker: ALNY
- cik: 0001178670
- company_name: ALNYLAM PHARMACEUTICALS, INC.
- filed_at: 2025-03-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178670/000117867025000031/0001178670-25-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178670/000117867025000031/alny-20250303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001178670-25-000031
- JSON: https://secwatch.observer/filing/0001178670-25-000031.json
- Plain text: https://secwatch.observer/filing/0001178670-25-000031.txt

## Key facts
- Executive change
  Phillip A. Sharp retired as Director at ALNYLAM PHARMACEUTICALS, INC..
  - Action: retired
  - Role: Director
  source text: On March 3, 2025, Phillip A. Sharp, Ph.D. informed the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”) of his retirement from the Board, effective as of May 8, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178670/000117867025000031/0001178670-25-000031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.